About us | Cedar Rose

Vet global suppliers and distributors with reputational and legal insights.

Healthcare and pharmaceutical organisations need partner networks that can withstand regulatory scrutiny and protect patient safety. Every supplier, contract manufacturer, logistics provider, and research partner must be legitimate, traceable, and compliant. Cedar Rose delivers verified, multilingual intelligence that supports safe sourcing, ethical collaboration, and resilient supply chains in both mature and high-risk markets.

Cross-Border Supplier Verification for Healthcare: Clear Ownership, Trusted Decisions

Operating across borders introduces complex risks: inconsistent documentation standards, fragmented public records, counterfeit threats, and opaque ownership structures. Healthcare and pharma teams must confirm not only who supplies critical products, but also who ultimately controls each organisation. Cedar Rose consolidates legal, financial, and reputational data into decision-ready insight, helping teams vet partners, protect patients, and stay ahead of regulatory expectations.

KYB & Supplier Verification

Verified registration, licensing status, governance, and ownership provide assurance that manufacturers, distributors, logistics firms, and research partners are legitimate and compliant. This reduces exposure to shell entities, unlicensed operators, and intermediaries that introduce counterfeit products or regulatory breaches into sensitive supply chains.

Sanctions, PEP & Adverse Media Screening

Screening across global sanctions lists, political exposure databases, and multilingual adverse media highlights suppliers linked to embargoed regimes, corruption cases, or serious quality failures. These insights help healthcare organisations avoid high-risk actors, maintain regulatory alignment, and protect patients from unsafe or non-compliant products.

Credit Risk Assessment

Independent evaluation of financial strength, repayment behaviour, and operational resilience reveals whether suppliers can sustain long-term delivery commitments. Understanding liquidity, leverage, and historical performance helps procurement teams avoid partners likely to default, collapse mid-contract, or trigger shortages during critical demand peaks.

Corporate Linkage & Ownership Mapping

Detailed mapping of corporate hierarchies uncovers indirect ownership, control relationships, and hidden affiliations with sanctioned entities or high-risk networks. This clarity helps healthcare and pharma organisations prevent backdoor exposure to dubious actors and ensures that every supplier in the chain aligns with ethical and regulatory expectations.

Investigative Due Diligence

Human-led investigations combine multilingual research, local enquiries, legal checks, and reputation analysis to provide deeper insight into strategic or high-risk suppliers. This approach reveals undisclosed disputes, compliance failures, political ties, and governance weaknesses that automated tools alone are unlikely to detect.

Continuous Monitoring & Alerts

Ongoing monitoring tracks changes in legal status, sanctions exposure, leadership, ownership, credit standing, and reputational signals across approved suppliers worldwide. Automated alerts allow healthcare organisations to intervene early when risk indicators appear, protecting continuity of care and avoiding last-minute disruptions.

MEA Regional Expertise

Regional expertise across the Middle East, Africa, and frontier markets delivers reliable intelligence where documentation is fragmented or inconsistent. Multilingual analysts and in-market networks validate key details, helping healthcare organisations verify counterparties confidently in regions associated with counterfeit or substandard products.

API & Platform Integration

API-first delivery connects KYB checks, sanctions screening, credit assessment, and monitoring data directly into ERP, procurement, compliance, and supply-chain platforms. Automated workflows reduce manual review, accelerate supplier approval, and provide consistent, auditable evaluation across large, complex healthcare networks.

Enhanced Integrity Due Diligence

Enhanced investigations provide a holistic view of integrity risk across ownership, legal exposure, ethical conduct, and local reputation. Combining multilingual research, field-level validation, and regional insight, Cedar Rose helps organisations scrutinise critical suppliers whose failure or misconduct could directly impact patient safety.

Why Choose Us

Why Healthcare & Pharma Organisations Choose Cedar Rose

Regulatory assurance

Verified supplier intelligence supports compliance with healthcare, pharmaceutical, and financial-crime rules in every market.

Supply chain protection

Vetted partners and ongoing monitoring reduce the risk of disruptions, recalls, or shortages caused by unstable suppliers.

Fraud and counterfeit prevention

Ownership clarity and reputational screening help identify risky or fraudulent suppliers before they enter your network.

Cross-border visibility

Regional expertise and multilingual research provide clarity into ownership, control, and risk across opaque or fragmented markets.

Reputational safeguarding

Deeper due diligence protects patients, regulators, investors, and brands from association with unethical or unreliable suppliers.

Accessibility standards

Reports and documents follow WCAG and PDF-UA guidelines, ensuring inclusive review by clinical teams, auditors, and regulators.

Don’t Let Unreliable Data Derail Your Growth!

Incomplete unreliable data and limited risk visibility don't just slow your company down; they actively sabotage its growth. Without comprehensive standardised, reliable quality data, you expose your business to unnecessary risks which complicate your ability to analyse the market landscape, and develop effective strategies.

Worse yet, compliance missteps, especially in new markets, can lead to costly fines that stifle your growth and tarnish your reputation. All this is also compounded by slow, manual processes that leave you scrambling to keep up, ultimately costing you deals, partnerships, and valuable time.

The thing is, high growth often means high-risk exposure, and the only way to navigate risk is through data. When harnessed correctly, data serves as your north star, guiding you through the maze of growth.

Trusted by Healthcare Leaders. Built for Patient Safety.

Cedar Rose helps healthcare and pharmaceutical organisations build secure, compliant, and resilient supply networks. Our intelligence supports safe sourcing, ethical partnerships, and reliable delivery of medicines and medical devices across complex global markets. Whether assessing a new manufacturer, vetting a distributor, or reviewing existing suppliers, we provide verified insight that protects patients, safeguards reputations, satisfies regulators, and strengthens long-term trust.

REQUEST A SAMPLE REPORT

KNOW MORE

Schedule a call

Talk to a Compliance Specialist

Healthcare & Pharma